Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexandre V Ivachtchenko

Showing results (21-30 of 68) with videos related to

Pageof 7
Sort By:
Farmaco (Societa Chimica Italiana : 1989)|September 27, 2005
Synthesis and caspase-3 inhibitory activity of 8-sulfonyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]quinolinesDmitri V Kravchenko, Volodymyr M Kysil, Sergey E Tkachenko, et al.
Natural Product Research|June 7, 2006
Natural products as templates for bioactive compound libraries: part 2. Novel modifications of vasicine (peganine) core via efficient and regioselective generation of 3-lithiodeoxyvasicine and its stereoselective addition to aliphatic ketones section signSergey V Shevyakov, Olga I Davydova, Alex S Kiselyov, et al.
European Journal of Medicinal Chemistry|September 20, 2005
Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-substituted 4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo[3,4-c]quinoline-1,3-dionesDmitri V Kravchenko, Volodymyr M Kysil, Sergey E Tkachenko, et al.
Acta Crystallographica. Section E, Crystallographic Communications|January 11, 2020
Crystal structure, Hirshfeld analysis and a mol-ecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxa-diazol-3-yl]meth-yl}-2<i>H</i>-1,2,6-thia-diazine-4-carboxyl-ateAlexandre V Ivachtchenko, Sergiy M Kovalenko, Dmitry V Kravchenko, et al.
Expert Opinion on Therapeutic Patents|December 15, 2016
Small-molecule inhibitors of hepatitis C virus (HCV) non-structural protein 5A (NS5A): a patent review (2010-2015)Yan A Ivanenkov, Vladimir A Aladinskiy, Nikolay A Bushkov, et al.
Archiv Der Pharmazie|November 19, 2009
Synthesis and biological evaluation of novel 5,8-disubstituted-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b] indoles as 5-HT(6) and H(1) receptors antagonistsAlexandre V Ivachtchenko, Eugene B Frolov, Oleg D Mitkin, et al.
Molecular Diversity|May 10, 2015
Non-dopamine receptor ligands for the treatment of Parkinson's disease. Insight into the related chemical/property spaceYan A Ivanenkov, Mark S Veselov, Nina V Chufarova, et al.
Bioorganic & Medicinal Chemistry Letters|December 1, 2009
Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indolesAlexandre V Ivachtchenko, Eugen B Frolov, Oleg D Mitkin, et al.
The Journal of Organic Chemistry|February 12, 2005
New four-component Ugi-type reaction. Synthesis of heterocyclic structures containing a pyrrolo[1,2-a][1,4]diazepine fragmentAlexey P Ilyn, Andrey S Trifilenkov, Julia A Kuzovkova, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2024
Influenza C virus susceptibility to antivirals with different mechanisms of actionAnton Chesnokov, Andrei A Ivashchenko, Yoko Matsuzaki, et al.
Pageof 7

Showing results (21-30 of 68) with videos related to

Sort By:
Pageof 7
Farmaco (Societa Chimica Italiana : 1989)|September 27, 2005
Synthesis and caspase-3 inhibitory activity of 8-sulfonyl-1,3-dioxo-2,3-dihydro-1H-pyrrolo[3,4-c]quinolinesDmitri V Kravchenko, Volodymyr M Kysil, Sergey E Tkachenko, et al.
Natural Product Research|June 7, 2006
Natural products as templates for bioactive compound libraries: part 2. Novel modifications of vasicine (peganine) core via efficient and regioselective generation of 3-lithiodeoxyvasicine and its stereoselective addition to aliphatic ketones section signSergey V Shevyakov, Olga I Davydova, Alex S Kiselyov, et al.
European Journal of Medicinal Chemistry|September 20, 2005
Pyrrolo[3,4-c]quinoline-1,3-diones as potent caspase-3 inhibitors. Synthesis and SAR of 2-substituted 4-methyl-8-(morpholine-4-sulfonyl)-pyrrolo[3,4-c]quinoline-1,3-dionesDmitri V Kravchenko, Volodymyr M Kysil, Sergey E Tkachenko, et al.
Acta Crystallographica. Section E, Crystallographic Communications|January 11, 2020
Crystal structure, Hirshfeld analysis and a mol-ecular docking study of a new inhibitor of the Hepatitis B virus (HBV): ethyl 5-methyl-1,1-dioxo-2-{[5-(pentan-3-yl)-1,2,4-oxa-diazol-3-yl]meth-yl}-2<i>H</i>-1,2,6-thia-diazine-4-carboxyl-ateAlexandre V Ivachtchenko, Sergiy M Kovalenko, Dmitry V Kravchenko, et al.
Expert Opinion on Therapeutic Patents|December 15, 2016
Small-molecule inhibitors of hepatitis C virus (HCV) non-structural protein 5A (NS5A): a patent review (2010-2015)Yan A Ivanenkov, Vladimir A Aladinskiy, Nikolay A Bushkov, et al.
Archiv Der Pharmazie|November 19, 2009
Synthesis and biological evaluation of novel 5,8-disubstituted-2-methyl-2,3,4,5-tetrahydro-1H-pyrido[4,3-b] indoles as 5-HT(6) and H(1) receptors antagonistsAlexandre V Ivachtchenko, Eugene B Frolov, Oleg D Mitkin, et al.
Molecular Diversity|May 10, 2015
Non-dopamine receptor ligands for the treatment of Parkinson's disease. Insight into the related chemical/property spaceYan A Ivanenkov, Mark S Veselov, Nina V Chufarova, et al.
Bioorganic & Medicinal Chemistry Letters|December 1, 2009
Synthesis and biological activity of 5-styryl and 5-phenethyl-substituted 2,3,4,5-tetrahydro-1H-pyrido[4,3-b]indolesAlexandre V Ivachtchenko, Eugen B Frolov, Oleg D Mitkin, et al.
The Journal of Organic Chemistry|February 12, 2005
New four-component Ugi-type reaction. Synthesis of heterocyclic structures containing a pyrrolo[1,2-a][1,4]diazepine fragmentAlexey P Ilyn, Andrey S Trifilenkov, Julia A Kuzovkova, et al.
Antimicrobial Agents and Chemotherapy|April 8, 2024
Influenza C virus susceptibility to antivirals with different mechanisms of actionAnton Chesnokov, Andrei A Ivashchenko, Yoko Matsuzaki, et al.
Pageof 7